Shengyu Zhou Selected Research

Shengyu Zhou Research Topics

Disease

12	Lymphoma (Lymphomas) 07/2022 - 01/2009
10	Neoplasms (Cancer) 07/2022 - 01/2007
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2022 - 11/2018
7	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 05/2022 - 02/2015
4	Adenocarcinoma of Lung 10/2021 - 08/2008
3	Disease Progression 04/2022 - 01/2020
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2020 - 02/2015
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2017 - 01/2009
2	T-Cell Lymphoma (Lymphoma, T Cell) 07/2022 - 11/2019
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 07/2022 - 02/2015
2	Infections 01/2022 - 03/2021
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 06/2021 - 01/2021
2	Hypertension (High Blood Pressure) 01/2021 - 01/2020
2	Nasopharyngeal Carcinoma 01/2020 - 08/2015
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 02/2017 - 10/2016
2	Neutropenia 02/2017 - 01/2016
2	B-Cell Lymphoma (Lymphoma, B Cell) 09/2015 - 02/2015
1	Stomach Neoplasms (Stomach Cancer) 07/2022
1	COVID-19 01/2022
1	Reinfection 03/2021
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Coronary Disease (Coronary Heart Disease) 01/2021
1	Drug-Related Side Effects and Adverse Reactions 12/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 12/2020
1	Neoplasm Metastasis (Metastasis) 12/2020
1	Brain Diseases (Brain Disorder) 01/2020
1	Proteinuria 01/2020
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2020
1	Alveolar Soft Part Sarcoma 01/2020
1	Pneumonia (Pneumonitis) 01/2020
1	Extranodal NK-T-Cell Lymphoma 11/2019
1	Brain Neoplasms (Brain Tumor) 06/2019
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Thrombocytopenia (Thrombopenia) 02/2017
1	Anemia 02/2017

Drug/Important Bio-Agent (IBA)

7	Rituximab (Mabthera)FDA Link 05/2022 - 09/2015
5	Gemcitabine FDA Link 11/2019 - 02/2014
4	PlatinumIBA 12/2020 - 08/2015
4	Cisplatin (Platino)FDA LinkGeneric 11/2019 - 10/2016
4	Guanosine Diphosphate (GDP)IBA 11/2019 - 10/2016
4	Dexamethasone (Maxidex)FDA LinkGeneric 11/2019 - 07/2015
3	Anaplastic Lymphoma KinaseIBA 07/2022 - 02/2015
3	Biomarkers (Surrogate Marker)IBA 07/2022 - 01/2020
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 05/2017 - 08/2014
2	Immunoglobulin G (IgG)IBA 07/2022 - 01/2020
2	AntibodiesIBA 07/2022 - 03/2021
2	EnzymesIBA 07/2022 - 01/2020
2	AutoantibodiesIBA 07/2022 - 01/2020
2	AnthracyclinesIBA 04/2022 - 11/2019
2	Tyrosine Kinase InhibitorsIBA 10/2021 - 06/2019
2	RNA (Ribonucleic Acid)IBA 03/2021 - 08/2015
2	Pemetrexed (MTA)FDA Link 10/2019 - 11/2018
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2017 - 09/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2015 - 08/2014
2	Ifosfamide FDA LinkGeneric 08/2015 - 07/2015
1	LigandsIBA 07/2022
1	MicronutrientsIBA 01/2022
1	Hydroxyl RadicalIBA 11/2021
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 11/2021
1	hydroxide ionIBA 11/2021
1	ErbB Receptors (EGF Receptor)IBA 10/2021
1	anlotinibIBA 10/2021
1	pembrolizumabIBA 10/2021
1	osimertinibIBA 10/2021
1	Thrombopoietin (c-mpl Ligand)IBA 09/2021
1	ProcalcitoninIBA 01/2021
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	fibrin fragment D (D-dimer)IBA 01/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2020
1	Carboplatin (JM8)FDA LinkGeneric 12/2020
1	Bevacizumab (Avastin)FDA Link 12/2020
1	Monoclonal AntibodiesIBA 12/2020
1	Sunitinib (Sutent)FDA Link 12/2020
1	Programmed Cell Death 1 ReceptorIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	apatinibIBA 01/2020
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2020
1	ibrutinibIBA 01/2020
1	Nucleic AcidsIBA 01/2020
1	AntioxidantsIBA 01/2020
1	nimotuzumabIBA 01/2020
1	Circulating Tumor DNAIBA 10/2019
1	icotinibIBA 06/2019
1	EndostatinsIBA 11/2018
1	endostar proteinIBA 11/2018
1	Therapeutic UsesIBA 01/2018
1	Growth Factor ReceptorsIBA 01/2018
1	Etoposide (VP 16)FDA LinkGeneric 10/2017
1	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2017
1	Carmustine (FIVB)FDA Link 10/2017
1	Melphalan (Alkeran)FDA LinkGeneric 10/2017
1	Filgrastim (Neupogen)FDA Link 01/2016

Therapy/Procedure

23	Drug Therapy (Chemotherapy) 04/2022 - 01/2007
7	Therapeutics 07/2022 - 10/2014
3	Radiotherapy 11/2019 - 01/2009
2	Stem Cell Transplantation 04/2022 - 01/2009
2	Hematopoietic Stem Cell Transplantation 10/2017 - 02/2015
1	Autologous Transplantation 09/2021
1	Nephrectomy 12/2020
1	VAP-cyclo protocol 10/2015